Oradell, NJ, United States of America

Martin J Weiss

USPTO Granted Patents = 85 

Average Co-Inventor Count = 2.7

ph-index = 11

Forward Citations = 1,660(Granted Patents)


Inventors with similar research interests:


Location History:

  • Oredell, NJ (US) (1978)
  • Bergen, NJ (US) (1980)
  • Oradell, NJ (US) (1976 - 1985)
  • Fort Lee, NJ (US) (1988 - 1989)
  • Ft. Lee, NJ (US) (1998 - 1999)

Company Filing History:


Years Active: 1976-1999

Loading Chart...
85 patents (USPTO):Explore Patents

Title: Martin J Weiss: Innovator in Antitumor Agents

Introduction

Martin J Weiss, based in Oradell, NJ, is a prolific inventor with an impressive track record of 85 patents. His innovative contributions primarily focus on the development of conjugates that leverage disulfide analogs of powerful antitumor antibiotics, showcasing his commitment to advancing cancer treatment.

Latest Patents

Among his latest patents are remarkable inventions related to the preparation of conjugates of methyltrithio antitumor agents. This invention outlines a process for creating carrier-drug conjugates derived from the calicheamicin family of potent antitumor antibiotics, alongside derivatives and related analogs from other antitumor antibiotics like esperamicins. The innovations involve the use of carriers, including antibodies, growth factors, or steroids, designed to target undesirable cell populations such as tumor cells. Furthermore, his patents encompass the necessary compounds for synthesizing these conjugates, appropriate pharmaceutical compositions, and comprehensive methods for their application.

Career Highlights

Throughout his career, Martin has made significant strides in the field of biotechnology. He has worked with esteemed organizations, including the American Cyanamid Company, where he contributed to various research initiatives and the advancement of pharmaceutical science.

Collaborations

In his professional journey, Martin collaborated with notable individuals such as Robert E Schaub and Charles V Grudzinskas, further enhancing the scope and impact of his work in the pharmaceutical industry.

Conclusion

Martin J Weiss stands out as a key figure in the fight against cancer through innovative drug delivery systems. His extensive patent portfolio exemplifies his dedication to improving therapeutic options for patients while opening avenues for further research and collaboration in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…